Medacta Group SA (SWX:MOVE)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
152.40
+0.80 (0.53%)
Feb 20, 2026, 4:34 PM CET
Market Cap3.02B +30.9%
Revenue (ttm)603.41M +18.7%
Net Income88.67M +68.9%
EPS4.45 +69.5%
Shares Out19.94M
PE Ratio34.10
Forward PE33.86
Dividend0.69 (0.46%)
Ex-Dividend DateMay 9, 2025
Volume9,487
Average Volume18,968
Open152.00
Previous Close151.60
Day's Range150.20 - 153.40
52-Week Range104.60 - 177.20
Beta1.18
RSI40.55
Earnings DateMar 13, 2026

About Medacta Group

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland. [Read more]

Sector Healthcare
Founded 1958
Employees 2,041
Stock Exchange SIX Swiss Exchange
Ticker Symbol MOVE
Full Company Profile

Financial Performance

In 2024, Medacta Group's revenue was 590.58 million, an increase of 15.62% compared to the previous year's 510.78 million. Earnings were 72.89 million, an increase of 53.89%.

Financial numbers in EUR Financial Statements

News

Medacta Group SA (MEDGF) Q4 2025 Sales/Trading Call Transcript

Medacta Group SA (MEDGF) Q4 2025 Sales/Trading Call February 3, 2026 9:00 AM ESTCompany ParticipantsFrancesco Siccardi - Chief Executive OfficerConference...

16 days ago - Seeking Alpha